Comparative Analysis of Spontaneous and Mycobacterial Antigen-Induced Secretion of Th1, Th2 and Pro-Inflammatory Cytokines by Peripheral Blood Mononuclear Cells of Tuberculosis Patients

Scandinavian Journal of Immunology

Volumn 75, Issue 6, 2012, Pages 623-632

  Al Attiyah, R ^a   El Shazly, A ^a   Mustafa, A S ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; MYCOBACTERIUM ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERIAL GENE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; LUNG TUBERCULOSIS; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGION OF DIFFERENCE 1; TH1 CELL; TH2 CELL;

ADULT; ANTIGENS, BACTERIAL; CYTOKINES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; TH1 CELLS; TH2 CELLS; TUBERCULOSIS, PULMONARY;

EID: 84861462913     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02692.x     Document Type: Article

References (51)

1. Kaufmann SHE. How can immunology contribute to the control of tuberculosis? Nat Rev Immunol 2001;1:20-30.
2. Espinal MA, Laszlo A, Simonsen L et al. Global trends in resistance to anti-tuberculosis drugs. World Health Organization - International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. New Engl J Med 2001;344:1294-303.
3. Wiker HG, Mustafa T, Bjune GA, Harboe M. Evidence for waning of latency in a cohort study of tuberculosis. BMC Infect Dis 2010;10:37.
4. Winqvist N, Björk J, Miörner H, Björkman P. Long-term course of Mycobacterium tuberculosis infection in Swedish birth cohorts during the twentieth century. Int J Tuberc Lung Dis 2011;15:736-40.
5. van Crevel R, Ottenhoff THM, van der Meer JWM. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 2002;1:294-309.
6. Flynn J. Immunology of tuberculosis and implications in vaccine development. Tuberculosis 2004;4:93-101.
7. Langermans JA, Andersen P, Van Soolingen D et al. Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc Natl Acad Sci U S A 2001;98:11497-502.
8. Buddle BM, Wedlock DN, Parlane NA, Corner LA, De Lisle GW, Skinner MA. Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination. Infect Immun 2003;7:6411-9.
9. Mittrücker HW, Steinhoff U, Köhler A et al. Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proc Natl Acad Sci U S A 2007;104:12434-9.
10. Caccamo N, Guggino G, Joosten SA et al. Multifunctional CD4 (+) T cell correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 2010;40:2211-20.
11. Bai X, Wilson SE, Chmura K, Feldman NE, Chan ED. Morphometric analysis of Th(1) and Th(2) cytokine expression in human pulmonary tuberculosis. Tuberculosis 2004;84:375-85.
12. Rook GA, Zumla A. Advances in the immunopathogenesis of pulmonary tuberculosis. Curr Opin Pulm Med 2001;7:116-23.
13. Trinchieri G. Interleukin-10 production by effector T cells: Th1 cells show self control. J Exp Med 2007;204:239-43.
14. Turner J, Gonzalez-Juarrero M, Ellis DL et al. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol 2002;169:6343-51.
15. Ehlers S. Immunity to tuberculosis: a delicate balance between protection and pathology. FEMS Immunol Med Microbiol 1999;23:149-58.
16. Zhang M, Lin Y, Iyer D, Gong J, Abrams J, Barnes P. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 1995;63:3231-4.
17. Mustafa AS. Vaccine potential of Mycobacterium tuberculosis-specific genomic regions: in vitro studies in humans. Expert Rev Vaccines 2009;8:1309-12.
18. Mustafa AS, Shaban FA, Abal AT et al. Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(1) T-cell lines. Infect Immun 2000;68:3933-40.
19. Mustafa AS, Shaban FA. ProPred analysis and experimental evaluation of promiscuous T-cell epitopes of three major secreted antigens of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2006;86:115-24.
20. Mustafa AS. HLA-promiscuous Th1-cell reactivity of MPT64 (Rv1980c), a major secreted antigen of Mycobacterium tuberculosis, in healthy subjects. Med Princ Pract 2009;18:385-92.
21. Mustafa AS. Comparative evaluation of MPT83 (Rv2873) for T Helper-1 cell reactivity and identification of HLA-promiscuous peptides in Mycobacterium bovis BCG-vaccinated healthy subjects. Clin Vaccine Immunol 2011;18:1752-9.
22. Al-Attiyah R, Mustafa AS. Characterization of human cellular immune responses to novel Mycobacterium tuberculosis antigens encoded by genomic regions absent in Mycobacterium bovis BCG. Infect Immun 2008;76:4190-8.
23. Mustafa AS, Al-Attiyah R. Identification of Mycobacterium tuberculosis-specific genomic regions encoding antigens inducing protective cellular immune responses. Indian J Exp Biol 2009;47:498-504.
24. Mustafa AS. Th1 cell reactivity and HLA-DR binding prediction for promiscuous recognition of MPT63 (Rv1926c), a major secreted protein of Mycobacterium tuberculosis. Scand J Immunol 2009;69:213-22.
25. Al-Attiyah R, Mustafa AS. Characterization of human cellular immune responses to Mycobacterium tuberculosis proteins encoded by genes predicted in RD15 genomic region that is absent in Mycobacterium bovis BCG. FEMS Immunol Med Microbiol 2010;59:177-87.
26. Mustafa AS. In silico binding predictions for identification of HLA-DR-promiscuous regions and epitopes of Mycobacterium tuberculosis protein MPT64 (Rv1980c) and their recognition by human Th1 cells. Med Princ Pract 2010;19:367-72.
27. Al-Attiyah R, Mustafa AS. Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guerin (BCG)-vaccinated healthy subjects. Clin Exp Immunol 2009;158:64-73.
28. Mustafa AS. Cell mediated immunity assays identify proteins of diagnostic and vaccine potential from genomic regions of difference of Mycobacterium tuberculosis. Kuwait Med J 2010;42:98-105.
29. Al-Attiyah R, Madi N, El-Shamy AS, Wiker H, Andersen P, Mustafa AS. Cytokine profiles in tuberculosis patients and healthy subjects in response to complex and single antigens of Mycobacterium tuberculosis. FEMS Immunol Med Microbiol 2006;47:254-61.
30. Mustafa AS, Al-Saidi F, El-Shamy AS, Al-Attiyah R. Cytokines in response to proteins predicted in genomic regions of difference of Mycobacterium tuberculosis. Microbiol Immunol 2011;55:267-78.
31. Rey AD, Mahuad CV, Bozza VV et al. Endocrine and cytokine responses in humans with pulmonary tuberculosis. Brain Behav Immun 2007;21:171-9.
32. Somoskövi A, Zissel G, Zipfel PF et al. Different cytokine patterns correlate with the extension of disease in pulmonary tuberculosis. Eur Cytokine Netw 1999;10:135-42.
33. Jo EL, Park JK, Dockrell HM. Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr Opin Infect Dis 2003;16:205-10.
34. Nakaya M, Yoneda T, Yoshikawa M et al. The evaluation of interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-alpha) level in peripheral blood of patients with active pulmonary tuberculosis. Kekkaku 1995;70:461-6.
35. Sadek MI, Sada E, Toossi Z, Schwander SK, Rich EA. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am J Respir Cell Mol Biol 1998;19:513-21.
36. Wang CH, Lin HC, Liu YC. Upregulation of inducible nitric oxide synthase and cytokine secretion in peripheral blood monocytes from pulmonary tuberculosis patients. Int J Tuberc Lung Dis 2001;5:283-91.
37. Raupach B, Kaufmann SHE. Immune responses to intracellular bacteria. Curr Opin Immunol 2001;13:417-28.
38. Arias MA, Pantoja AE, Jaramillo G et al. Chemokine/cytokine production by mononuclear cells from human lymphoid tissues and their modulation by Mycobacterium tuberculosis antigens. FEMS Immunol Med Microbiol 2007;49:272-9.
39. Stadler BM, Dougherty SF, Farrar JJ, Oppenheim JJ. Relationship of cell cycle to recovery of IL-2 activity from human mononuclear cells, human and mouse T cell lines. J Immunol 1981;127:1936-40.
40. Tsunoda T, Tanimura H, Yamaue H et al. Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4. Br J Cancer 1996;74:1085-9.
41. Sabat R, Grütz G, Warszawska K et al. Biology of interleukin-10. Cytokine Growth Factor Rev 2010;21:331-44.
42. Smith SG, Lalor MK, Gorak-Stolinska P et al. Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining. BMC Immunol 2010;11:35.
43. Gong J, Zhang M, Modlin RL et al. Interleukin-10 downregulates Mycobacterium tuberculosis induced Th1 responses and CLTA-4 expression. Infect Immun 1996;9:913-8.
44. North RJ. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin Exp Immunol 1998;113:55-8.
45. Murray PJ, Wang L, Onufryk C, Tepper RI, Young RA. T cell- derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 1997;158:315-21.
46. Jamil B, Shahid F, Hasa Z et al. Interferon g/IL-10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis. Tuberculosis 2007;87:279-87.
47. Katsikis PD, Cohen SB, Londei M, Feldmann M. Are CD4+ Th1 cells pro-inflammatory or anti-inflammatory? The ratio of IL-10 to IFN-gamma or IL-2 determines their function Int Immunol. 1995;7:1287-94.
48. Lienhardt C, Azzurri A, Amedei A et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol 2002;32:1605-13.
49. Sahiratmadja E, Alisjahbana B, de Boer T et al. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun 2007;75:820-9.
50. Mustafa AS, Al-Attiyah R, Hanif SN, Shaban FA. Efficient testing of large pools of Mycobacterium tuberculosis RD1 peptides and identification of major antigens and immunodominant peptides recognized by human Th1 cells. Clin Vaccine Immunol 2008;15:916-24.
51. Flynn J. Why is IFN-gamma insufficient to control tuberculosis? Trends Microbiol 1999;7:477-8.